Found: 103
Select item for more details and to access through your institution.
Futibatinib: A Review in Locally Advanced and Metastatic Cholangiocarcinoma.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 473, doi. 10.1007/s11523-024-01059-8
- By:
- Publication type:
- Article
Exagamglogene Autotemcel: First Approval.
- Published in:
- Molecular Diagnosis & Therapy, 2024, v. 28, n. 2, p. 133, doi. 10.1007/s40291-024-00696-z
- By:
- Publication type:
- Article
Bosutinib: Pediatric First Approval.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 2, p. 209, doi. 10.1007/s40272-023-00608-4
- By:
- Publication type:
- Article
Correction: Elacestrant: First Approval.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: Motixafortide: First Approval.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Motixafortide: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1635, doi. 10.1007/s40265-023-01962-w
- By:
- Publication type:
- Article
Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea.
- Published in:
- CNS Drugs, 2023, v. 37, n. 11, p. 1009, doi. 10.1007/s40263-023-01040-5
- By:
- Publication type:
- Article
Pozelimab: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 16, p. 1551, doi. 10.1007/s40265-023-01955-9
- By:
- Publication type:
- Article
Correction to: Rozanolixizumab: First Approval.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Delandistrogene Moxeparvovec: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 14, p. 1323, doi. 10.1007/s40265-023-01929-x
- By:
- Publication type:
- Article
Rozanolixizumab: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 14, p. 1341, doi. 10.1007/s40265-023-01933-1
- By:
- Publication type:
- Article
Manage androgenetic alopecia in men with established options but emerging therapies show promise.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 8, p. 292, doi. 10.1007/s40267-023-01011-2
- By:
- Publication type:
- Article
Eftrenonacog Alfa: A Review in Haemophilia B.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 807, doi. 10.1007/s40265-023-01868-7
- By:
- Publication type:
- Article
Correction to: Eftrenonacog Alfa: A Review in Haemophilia B.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Take an individualized and multipronged approach when managing older adults with type 2 diabetes.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 5, p. 171, doi. 10.1007/s40267-023-00991-5
- By:
- Publication type:
- Article
Elacestrant: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 6, p. 555, doi. 10.1007/s40265-023-01861-0
- By:
- Publication type:
- Article
Bexagliflozin: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 5, p. 447, doi. 10.1007/s40265-023-01848-x
- By:
- Publication type:
- Article
Lecanemab: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 4, p. 359, doi. 10.1007/s40265-023-01851-2
- By:
- Publication type:
- Article
Avacopan in granulomatosis with polyangiitis and microscopic polyangiitis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 2, p. 48, doi. 10.1007/s40267-022-00974-y
- By:
- Publication type:
- Article
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 1, p. 143, doi. 10.1007/s40257-022-00748-2
- By:
- Publication type:
- Article
Deucravacitinib: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 17, p. 1671, doi. 10.1007/s40265-022-01796-y
- By:
- Publication type:
- Article
Correction to: Baricitinib: A Review in Moderate to Severe Atopic Dermatitis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Pimitespib: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 13, p. 1413, doi. 10.1007/s40265-022-01764-6
- By:
- Publication type:
- Article
Diagnose and treat paediatric-onset multiple sclerosis promptly to delay physical worsening and cognitive decline.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 9, p. 389, doi. 10.1007/s40267-022-00938-2
- By:
- Publication type:
- Article
Amubarvimab/Romlusevimab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1327, doi. 10.1007/s40265-022-01759-3
- By:
- Publication type:
- Article
Baricitinib: A Review in Moderate to Severe Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 3, p. 409, doi. 10.1007/s40257-022-00684-1
- By:
- Publication type:
- Article
Palovarotene: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 6, p. 711, doi. 10.1007/s40265-022-01709-z
- By:
- Publication type:
- Article
Tezepelumab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 4, p. 461, doi. 10.1007/s40265-022-01679-2
- By:
- Publication type:
- Article
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Nusinersen: A Review in 5q Spinal Muscular Atrophy.
- Published in:
- CNS Drugs, 2021, v. 35, n. 12, p. 1317, doi. 10.1007/s40263-021-00878-x
- By:
- Publication type:
- Article
Correction to: Contezolid: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Contezolid: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1587, doi. 10.1007/s40265-021-01576-0
- By:
- Publication type:
- Article
Upacicalcet: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1593, doi. 10.1007/s40265-021-01578-y
- By:
- Publication type:
- Article
Pegcetacoplan: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 12, p. 1423, doi. 10.1007/s40265-021-01560-8
- By:
- Publication type:
- Article
Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 405, doi. 10.1007/s40261-021-01010-z
- By:
- Publication type:
- Article
Brigatinib: A Review in ALK-Inhibitor Naïve Advanced ALK-Positive NSCLC.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 267, doi. 10.1007/s40265-020-01449-y
- By:
- Publication type:
- Article
Tafasitamab: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1731, doi. 10.1007/s40265-020-01405-w
- By:
- Publication type:
- Article
Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer.
- Published in:
- Drugs, 2020, v. 80, n. 15, p. 1579, doi. 10.1007/s40265-020-01401-0
- By:
- Publication type:
- Article
Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Pemigatinib: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 9, p. 923, doi. 10.1007/s40265-020-01330-y
- By:
- Publication type:
- Article
Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps.
- Published in:
- Drugs, 2020, v. 80, n. 7, p. 711, doi. 10.1007/s40265-020-01298-9
- By:
- Publication type:
- Article
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus.
- Published in:
- BioDrugs, 2020, v. 34, n. 2, p. 245, doi. 10.1007/s40259-020-00418-x
- By:
- Publication type:
- Article
Tazemetostat: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 513, doi. 10.1007/s40265-020-01288-x
- By:
- Publication type:
- Article
Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 1, p. 83, doi. 10.1007/s40261-019-00867-5
- By:
- Publication type:
- Article
Elexacaftor/Ivacaftor/Tezacaftor: First Approval.
- Published in:
- Drugs, 2019, v. 79, n. 18, p. 2001, doi. 10.1007/s40265-019-01233-7
- By:
- Publication type:
- Article
Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease.
- Published in:
- Drugs, 2019, v. 79, n. 15, p. 1709, doi. 10.1007/s40265-019-01201-1
- By:
- Publication type:
- Article
Onasemnogene Abeparvovec: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1255, doi. 10.1007/s40265-019-01162-5
- By:
- Publication type:
- Article
Rifamycin SV MMX<sup>®</sup>: A Review in the Treatment of Traveller's Diarrhoea.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 7, p. 691, doi. 10.1007/s40261-019-00819-z
- By:
- Publication type:
- Article